{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:59:13Z","timestamp":1788274753082,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00277-025-06556-y","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:46:14Z","timestamp":1755845174000},"page":"4487-4494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study"],"prefix":"10.1007","volume":"104","author":[{"given":"Alessandra","family":"D\u2019Addio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Rondoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Salvucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Tanasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Perbellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Tomassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evita","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zingaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lucchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Bochicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Krampera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"Suppl 4","key":"6556_CR1","first-page":"S20","volume":"98","author":"J Panse","year":"2023","unstructured":"Panse J (2023) Paroxysmal nocturnal hemoglobinuria: where we stand. Am J Hematol 98(Suppl 4):S20\u2013S32","journal-title":"Am J Hematol"},{"issue":"2","key":"6556_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMra2201664","volume":"387","author":"R Notaro","year":"2022","unstructured":"Notaro R, Luzzatto L (2022) Breakthrough hemolysis in PNH with proximal or terminal complement inhibition. N Engl J Med 387(2):160\u2013166. https:\/\/doi.org\/10.1056\/NEJMra2201664","journal-title":"N Engl J Med"},{"issue":"1","key":"6556_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1200\/JCO.22.00710","volume":"41","author":"C Gurnari","year":"2023","unstructured":"Gurnari C, Pagliuca S, Prata PH et al (2023) Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. J Clin Oncol 41(1):132\u2013142","journal-title":"J Clin Oncol"},{"issue":"2","key":"6556_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1182\/blood.2024023988","volume":"144","author":"C Gurnari","year":"2024","unstructured":"Gurnari C, Awada H, Pagliuca S et al (2024) Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis. Blood 144(2):145\u2013155","journal-title":"Blood"},{"key":"6556_CR5","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","volume":"106","author":"C Parker","year":"2005","unstructured":"Parker C, Omine M, Richards S et al (2005) Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106:3699\u20133709","journal-title":"Blood"},{"key":"6556_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","volume":"73","author":"J Takeda","year":"1993","unstructured":"Takeda J, Miyata T, Kawagoe K et al (1993) Deficiency of the GPI anchor caused by a somatic mutationof the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703\u2013711","journal-title":"Cell"},{"issue":"11","key":"6556_CR7","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1182\/blood.V83.11.3126.3126","volume":"83","author":"B Yoshiyasu","year":"1994","unstructured":"Yoshiyasu B et al (1994) Characterization of genomic PIG-A gene: a gene for Glycosylphosphatidylinositol-anchor byosinthesis and paroxysmal nocturnal hemoglobinuria. Blood 83(11):3126\u20133313","journal-title":"Blood"},{"issue":"1","key":"6556_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/cyto.b.21610","volume":"94","author":"DR Sutherland","year":"2018","unstructured":"Sutherland DR, Illingworth A, Marinov I et al (2018) ICCS\/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 - reagent selection and assay optimization for high-sensitivity testing. Cytometry B Clin Cytom 94(1):23\u201348","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"6556_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/cyto.b.21608","volume":"94","author":"AE Dezern","year":"2018","unstructured":"Dezern AE, Borowitz MJ (2018) ICCS\/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 1 - clinical utility. Cytometry B Clin Cytom 94(1):16\u201322","journal-title":"Cytometry B Clin Cytom"},{"key":"6556_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1529-1049(01)00034-4","volume":"1","author":"SJ Richards","year":"2001","unstructured":"Richards SJ, Hill A, Hillmen P (2001) Recent advances in laboratory diagnosis of PNH. Clin Appl Immunol Rev 1:315\u2013330","journal-title":"Clin Appl Immunol Rev"},{"issue":"4","key":"6556_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cyto.b.20525","volume":"78","author":"MJ Borowitz","year":"2010","unstructured":"Borowitz MJ, Craig FE, Digiuseppe JA et al (2010) Clinical cytometry society. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom 78(4):211\u2013230","journal-title":"Cytometry B Clin Cytom"},{"issue":"5","key":"6556_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cytob.21174","volume":"4","author":"M Fletcher","year":"2014","unstructured":"Fletcher M, Sutherland DR, Whitby L et al (2014) Standardizing leucocyte PNH clone detection: an international study. Cytometry B Clin Cytom 4(5):311\u2013318","journal-title":"Cytometry B Clin Cytom"},{"issue":"12","key":"6556_CR13","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","volume":"110","author":"P Hillmen","year":"2007","unstructured":"Hillmen P, Muus P, D\u00fchrsen U et al (2007) Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 110(12):4123\u20134128","journal-title":"Blood"},{"issue":"25","key":"6556_CR14","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","volume":"121","author":"A Hill","year":"2013","unstructured":"Hill A, Kelly RJ, Hillmen P (2013) Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 121(25):4985\u20134996","journal-title":"Blood"},{"issue":"6","key":"6556_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12185-013-1346-4","volume":"97","author":"JW Lee","year":"2013","unstructured":"Lee JW, Jang JH, Kim JS et al (2013) Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry. Int J Hematol 97(6):749\u201357","journal-title":"Int J Hematol"},{"key":"6556_CR16","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1182\/blood-2003-01-0009","volume":"102","author":"C Hall","year":"2003","unstructured":"Hall C, Richards S, Hillmen P (2003) Primary prophilaxys with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 102:3587\u20133591","journal-title":"Blood"},{"key":"6556_CR17","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00415-005-0871-3","volume":"252","author":"HJ Audebert","year":"2005","unstructured":"Audebert HJ, Planck J, Eisenburg M et al (2005) Cerebral ischemic infarction in paroxysmal nocturnal hemoglobinuria report of 2 cases and updated review of 7 previously published patients. J Neurol 252:1379\u20131386","journal-title":"J Neurol"},{"key":"6556_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","volume":"115","author":"T Barbui","year":"2010","unstructured":"Barbui T, Carobbio A, Cervantes F et al (2010) Thrombosis in primary myelofibrosis: incidence and risk factors. Blood 115:778\u2013782","journal-title":"Blood"},{"key":"6556_CR19","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","volume":"23","author":"R Marchioli","year":"2005","unstructured":"Marchioli R, Finazzi G, Landolfi R et al (2005) Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol 23:2224\u20132232","journal-title":"J Clin Oncol"},{"key":"6556_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa043800","volume":"353","author":"CN Harrison","year":"2005","unstructured":"Harrison CN, Campbell PJ, Buck G et al (2005) United Kingdom medical research Council primary thrombocythemia 1 study. Hydroxyurea compared with Anagrelide in high-risk essential thrombocythemia. N Engl J Med 353:33\u201345","journal-title":"N Engl J Med"},{"key":"6556_CR21","first-page":"408","volume":"90","author":"H Gisslinger","year":"2005","unstructured":"Gisslinger H, Millner M, Pabinger I et al (2005) Mutation of the prothrombin gene and thrombotic events in patients with polycythemia Vera or essential thrombocythemia: a cohort study. Haematologica 90:408\u2013410","journal-title":"Haematologica"},{"issue":"12","key":"6556_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.clml.2019.07.441","volume":"19","author":"O Gutwein","year":"2019","unstructured":"Gutwein O, Englander Y, Herzog-Tzarfati K et al (2019) Prevalence of paroxysmal nocturnal hemoglobinuria clones in myeloproliferative neoplasm patients: a cross-sectional study. Clin Lymphoma Myeloma Leuk 19(12):812\u2013814","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"6556_CR23","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1038\/bcj.2012.7","volume":"2","author":"C Sugimori","year":"2012","unstructured":"Sugimori C, Padron E, Caceres G et al (2012) Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J 2(3):e63","journal-title":"Blood Cancer J"},{"key":"6556_CR24","first-page":"107","volume":"16","author":"YS Fraiman","year":"2016","unstructured":"Fraiman YS, Cuka N, Batista D et al (2016) Development of paroxysmal nocturnal hemoglobinuria in CALR-positive myeloproliferative neoplasm. J Blood Med 16:7:107\u2013110","journal-title":"J Blood Med"},{"issue":"3","key":"6556_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bcmd.2014.11.017","volume":"54","author":"S Chotirat","year":"2015","unstructured":"Chotirat S, Thongnoppakhun W, Wanachiwanawin W, Auewarakul CU (2015) Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders. Blood Cells Mol Dis 54(3):286\u2013291","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"6556_CR26","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1172\/JCI74747","volume":"24","author":"W Shen","year":"2014","unstructured":"Shen W, Clemente MJ, Hosono N et al (2014) Deep sequencing reveals Stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. J Clin Invest 24(10):4529\u20134538","journal-title":"J Clin Invest"},{"issue":"8","key":"6556_CR27","doi-asserted-by":"publisher","first-page":"e0182470","DOI":"10.1371\/journal.pone.0182470","volume":"12","author":"TL Ramos","year":"2017","unstructured":"Ramos TL, S\u00e1nchez-Abarca LI, Ros\u00f3n-Burgo B et al (2017) Mesenchymal stromal cells (MSC) from JAK2\u2009+\u2009myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis. PLoS One 12(8):e0182470","journal-title":"PLoS One"},{"issue":"3","key":"6556_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MBC.0000000000000724","volume":"29","author":"HY Lim","year":"2018","unstructured":"Lim HY, Ng C, Rigano J et al (2018) An evaluation of global coagulation assays in myeloproliferative neoplasm. Blood Coagul Fibrinolysis 29(3):300\u2013306","journal-title":"Blood Coagul Fibrinolysis"},{"key":"6556_CR29","first-page":"335","volume":"30","author":"B Brando","year":"2019","unstructured":"Brando B, Gatti A, Preijers F (2019) Flow cytometric diagnosis of paroxysmal nocturnal hemoglobinuria: pearls and pitfalls- a critical rewiew article. EJIFCC 30:335\u2013370","journal-title":"EJIFCC"},{"key":"6556_CR30","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3109\/10428194.2013.876628","volume":"55","author":"A Nazha","year":"2014","unstructured":"Nazha A, Jorgensen JL, Verstovsek S (2014) Paroxysmal nocturnal hemoglobinuria is not a cause of anemia in patients with myelofibrosis. Leuk Lymphoma 55:2215\u20132216","journal-title":"Leuk Lymphoma"},{"key":"6556_CR31","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1200\/JCO.1999.17.9.2954","volume":"17","author":"G Barosi","year":"1999","unstructured":"Barosi G (1999) Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 17:2954\u20132970","journal-title":"J Clin Oncol"},{"key":"6556_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.leukres.2017.03.006","volume":"57","author":"P Strati","year":"2017","unstructured":"Strati P, Masarova L, Bose P et al (2017) Haptoglobin is frequently low in patients with myelofibrosis: clinical relevance. Leuk Res 57:85\u201388","journal-title":"Leuk Res"},{"key":"6556_CR33","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserijian R et al (2016) The 2016 revision of the world health organization classification of myeloid neoplasm and acute leukemia. Blood 127:2391\u20132405","journal-title":"Blood"},{"key":"6556_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajh.10153","volume":"71","author":"M Ruggeri","year":"2002","unstructured":"Ruggeri M, Gisslinger H, Tostito A et al (2002) Factor V Leiden mutation carriership and venous thromboembolism in polycythemia Vera and essential thrombocythemia. Am J Hematol 71:1\u20136","journal-title":"Am J Hematol"},{"key":"6556_CR35","doi-asserted-by":"crossref","unstructured":"Gisslinger H, Gotic M, Holowiecki J, ANAHYDRET study group et al (2013) Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the anahydret study, a randomized controlled trial. Blood 121:1720\u20131728","DOI":"10.1182\/blood-2012-07-443770"},{"key":"6556_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3324\/haematol.13869","volume":"94","author":"V De Stefano","year":"2009","unstructured":"De Stefano V, Za T, Rossi E et al (2009) Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia. Haematologica 94:733\u2013737","journal-title":"Haematologica"},{"key":"6556_CR37","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3324\/haematol.12970","volume":"93","author":"PD Ziakas","year":"2008","unstructured":"Ziakas PD (2008) Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain. Haematologica 93:1412\u20131414","journal-title":"Haematologica"},{"key":"6556_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.leukres.2008.06.006","volume":"33","author":"IJ Dahari","year":"2009","unstructured":"Dahari IJ, Zoi K, Giannouli S et al (2009) Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia. Leuk Res 33:67\u201373","journal-title":"Leuk Res"},{"key":"6556_CR39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.thromres.2009.02.004","volume":"124","author":"F Lussana","year":"2009","unstructured":"Lussana F, Caberlon S, Pagani C et al (2009) Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review. Thromb Res 124:409\u2013417","journal-title":"Thromb Res"},{"key":"6556_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27456","author":"A Kulasekararaj","year":"2024","unstructured":"Kulasekararaj A, Lanza F, Arvanitakis A et al (2024) Comparative clinical efficacy and safety of biosimilar <scp>ABP<\/scp>959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.27456","journal-title":"Am J Hematol"},{"key":"6556_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/blood.V36.4.428.428","volume":"36","author":"NE Hansen","year":"1970","unstructured":"Hansen NE, Killmann SA (1970) Paroxysmal nocturnal hemoglobinuria in myelofibrosis. Blood 36:428\u2013431","journal-title":"Blood"},{"key":"6556_CR42","first-page":"13","volume":"64","author":"L Luzzatto","year":"1979","unstructured":"Luzzatto L, Familusi JB, Williams CK et al (1979) The PNH abnormality in myeloproliferative disorders: association of PNH and acute erythremicmyelosis in two children. Haematologica 64:13\u201330","journal-title":"Haematologica"},{"key":"6556_CR43","doi-asserted-by":"crossref","unstructured":"Shaheen SP 2nd, Talwalkar SS, Simons R, Yam L (2005) Acute lymphoblastic leukemic transformation in a patient with chronic idiopathic myelofibrosis and paroxysmal nocturnal hemoglobinuria: a case report and review of the literature. ArchPathol Lab Med 129(1):96\u201399","DOI":"10.5858\/2005-129-96-ALLTIA"},{"issue":"13","key":"6556_CR44","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1182\/blood-2006-05-025148","volume":"108","author":"N Inoue","year":"2006","unstructured":"Inoue N, Izui-Sarumaru T, Murakami Y et al (2006) Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood 108(13):4232\u20134236","journal-title":"Blood"},{"issue":"1","key":"6556_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1365-2141.2009.07822.x","volume":"147","author":"C Sugimori","year":"2009","unstructured":"Sugimori C, Mochizuki K, Qi Z et al (2009) Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure. Br J Haematol 147(1):102\u2013112 Epub 2009 Jul 28. PubMed PMID: 19656154","journal-title":"Br J Haematol"},{"issue":"6","key":"6556_CR46","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3109\/10428194.2014.953153","volume":"56","author":"C Sun","year":"2015","unstructured":"Sun C, Zhang S, Li J (2015) Calreticulin gene mutations in myeloprolifera\u00adtive neoplasms without Janus kinase 2 mutations. Leuk Lymphoma 56(6):1593\u20131598","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"6556_CR47","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1182\/blood.V92.9.3422","volume":"92","author":"K Nafa","year":"1998","unstructured":"Nafa K, Bessler M, Deeg HJ, Luzzatto L (1998) New somatic mutation in the PIG-A gene emerges at relapse of paroxysmal nocturnal hemoglobinuria. Blood 92(9):3422\u20133427","journal-title":"Blood"},{"key":"6556_CR48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","volume":"37","author":"HC Hasselbalch","year":"2013","unstructured":"Hasselbalch HC (2013) Chronic inflammation as a promotor of mutagenensis in essential thrombocytemia, polycitemia Vera and myelofibrosis. A human inflammmation model for cancer development?? Leuk Res 37:214\u2013220","journal-title":"Leuk Res"},{"key":"6556_CR49","doi-asserted-by":"publisher","first-page":"665037","DOI":"10.3389\/fonc.2021.665037","volume":"11","author":"JG Cominal","year":"2021","unstructured":"Cominal JG, Cacemiro MDC, Berzoti-Coelho MG et al (2021) Bone marrow soluble mediator signature of patients with Philadelphia Chromosome- negative myeloproliferative neoplasm. Front Oncol 11:665037","journal-title":"Front Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06556-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:02:32Z","timestamp":1761285752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6556"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06556-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies in this paper were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2008. All patients gave their informed consent prior to the inclusion of their data in the study database.This multicentre study was approved by CEROM Romagna Ethical Committe, Ethical Committee of Verona (Policlinico Universitario) and Vicenza (San Bortolo Hospital).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Patient consent was signed by all patients (n. 119).Tables and figures are original.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}